233 related articles for article (PubMed ID: 32744105)
1. Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia.
Yaman S; Ozdemir D; Akman BT; Cakir B; Ersoy O
Postgrad Med; 2021 Mar; 133(2):146-153. PubMed ID: 32744105
[TBL] [Abstract][Full Text] [Related]
2. Identifying undiagnosed or undertreated patients with familial hypercholesterolemia from the laboratory records of a tertiary medical center.
Haymana C; Berlik H; Güneş Y; Tunçez OE; Aytekin C; Tapıkara Z; Güzel H; Öztürk Ö; Barçın C; Özgürtaş T; Azal Ö; Sönmez A
Turk Kardiyol Dern Ars; 2017 Dec; 45(8):731-738. PubMed ID: 29226894
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
[TBL] [Abstract][Full Text] [Related]
5. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
Bucholz EM; Rodday AM; Kolor K; Khoury MJ; de Ferranti SD
Circulation; 2018 May; 137(21):2218-2230. PubMed ID: 29581125
[TBL] [Abstract][Full Text] [Related]
7. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
[TBL] [Abstract][Full Text] [Related]
8. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
Korneva V; Kuznetsova T; Julius U
Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
[TBL] [Abstract][Full Text] [Related]
10. The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study.
Teramoto T; Sawa T; Iimuro S; Inomata H; Koshimizu T; Sakakibara I; Hiramatsu K
Cardiovasc Ther; 2020; 2020():5936748. PubMed ID: 32636924
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
12. Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry.
Rizos CV; Florentin M; Skoumas I; Tziomalos K; Rallidis L; Kotsis V; Athyros V; Skalidis E; Kolovou G; Garoufi A; Bilianou E; Koutagiar I; Agapakis D; Kiouri E; Antza C; Katsiki N; Zacharis E; Attilakos A; Sfikas G; Anagnostis P; Panagiotakos DB; Liberopoulos EN
Lipids Health Dis; 2020 May; 19(1):114. PubMed ID: 32466791
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database.
Sonmez A; Demirci I; Haymana C; Tasci I; Ayvalı MO; Ata N; Ezgu FS; Bayram F; Barcin C; Caglayan M; Ülgü MM; Birinci S; Tokgozoglu L; Satman I; Kayikcioglu M
Atherosclerosis; 2023 Jun; 375():9-20. PubMed ID: 37216728
[TBL] [Abstract][Full Text] [Related]
14. Detection of familial hypercholesterolemia in patients from a general practice database.
Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice.
Catapano AL; Lautsch D; Tokgözoglu L; Ferrieres J; Horack M; Farnier M; Toth PP; Brudi P; Tomassini JE; Ambegaonkar B; Gitt AK
Atherosclerosis; 2016 Sep; 252():1-8. PubMed ID: 27494444
[TBL] [Abstract][Full Text] [Related]
17. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
Schmidt N; Dressel A; Grammer TB; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Koenig W; Otte B; Parhofer KG; Reinhard W; Schatz U; Schunkert H; Steinhagen-Thiessen E; Vogt A; Laufs U; März W
Atherosclerosis; 2018 Oct; 277():314-322. PubMed ID: 30270065
[TBL] [Abstract][Full Text] [Related]
18. Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan.
Teramoto T; Kai T; Ozaki A; Crawford B; Arai H; Yamashita S
J Atheroscler Thromb; 2018 Jul; 25(7):580-592. PubMed ID: 29353825
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
20. Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.
Safarova MS; Liu H; Kullo IJ
J Clin Lipidol; 2016; 10(5):1230-9. PubMed ID: 27678441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
